Joint Guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT) on the Diagnosis and Management of Chronic Obstructive Pulmonary Disease

[1]  P. Poole,et al.  Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. , 2010, The Cochrane database of systematic reviews.

[2]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[3]  L. Stead,et al.  Nicotine receptor partial agonists for smoking cessation (Review) , 2007 .

[4]  Thierry Troosters,et al.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.

[5]  P. Schnohr,et al.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study , 2006, Thorax.

[6]  F. Venuta,et al.  Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. , 2006, Chest.

[7]  J. Garcia-Aymerich,et al.  Wood smoke exposure and risk of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[8]  L. Puente-Maestu,et al.  [Guidelines for the evaluation of surgical risk in bronchogenic carcinoma]. , 2005, Archivos de bronconeumologia.

[9]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[10]  J. Muñoz,et al.  Clinical efficacy of anti-pneumococcal vaccination in patients with COPD , 2005, Thorax.

[11]  E. Bateman,et al.  Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial , 2005, The Lancet.

[12]  J. V. van Noord,et al.  Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD , 2005, European Respiratory Journal.

[13]  J. Barberà,et al.  Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. , 2005, Chest.

[14]  D. Postma,et al.  Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial , 2005, Thorax.

[15]  F. Baquero,et al.  Geographical and Ecological Analysis of Resistance, Coresistance, and Coupled Resistance to Antimicrobials in Respiratory Pathogenic Bacteria in Spain , 2005, Antimicrobial Agents and Chemotherapy.

[16]  M. Decramer,et al.  Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.

[17]  R. Pérez,et al.  Normativa sobre valoración del riesgo quirúrgico en el carcinoma broncogénico , 2005 .

[18]  J. Orens,et al.  Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness , 2004, European Respiratory Journal.

[19]  F. García-Río,et al.  Spirometric reference equations for European females and males aged 65–85 yrs , 2004, European Respiratory Journal.

[20]  B. Make,et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.

[21]  P. Calverley.  Breathlessness during exercise in COPD: how do the drugs work? , 2004, Thorax.

[22]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[23]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[24]  S. Spencer,et al.  Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.

[25]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[26]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[27]  E. Ingenito,et al.  Bronchoscopic lung volume reduction using tissue engineering principles. , 2003, American journal of respiratory and critical care medicine.

[28]  A. Simonds.  Ethics and decision making in end stage lung disease , 2003, Thorax.

[29]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[30]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[31]  P. Jones,et al.  Oral theophylline for chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[32]  A. Corrado,et al.  The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients , 2002, European Respiratory Journal.

[33]  M. Decramer,et al.  Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial , 2002, European Respiratory Journal.

[34]  Steven Piantadosi,et al.  Patients at high risk of death after lung-volume-reduction surgery. , 2001, The New England journal of medicine.

[35]  A. Roman,et al.  [SEPAR (Spanish Society of Pneumology and Thoracic Surgery) Guidelines. Lung transplantation]. , 2001, Archivos de bronconeumologia.

[36]  J. Tu,et al.  Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[37]  A. Agustí,et al.  Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD. , 2001, The European respiratory journal.

[38]  R. Wood‐Baker,et al.  Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. , 2001, The Cochrane database of systematic reviews.

[39]  R. Perera,et al.  Nicotine replacement therapy for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[40]  B. Celli,et al.  Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. , 2000, Chest.

[41]  T. Rubio,et al.  Results of a home-based training program for patients with COPD. , 2000, Chest.

[42]  P. Plant,et al.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.

[43]  B. Whipp,et al.  Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. , 2000, The European respiratory journal.

[44]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[45]  P. Lucas,et al.  Normativa sobre la rehabilitación respiratoria , 2000 .

[46]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[47]  tefan,et al.  LONG-TERM TREATMENT WITH INHALED BUDESONIDE IN PERSONS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO CONTINUE SMOKING , 2000 .

[48]  C. Ruiz.  Normativa para el tratamiento del tabaquismo , 1999 .

[49]  A. Agustí,et al.  Oxygen therapy during exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[50]  M. Miravitlles,et al.  Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo , 1999 .

[51]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[52]  K. Nichol,et al.  Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease , 1999, Annals of Internal Medicine.

[53]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[54]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[55]  M. Estenne,et al.  International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, Heart & lung : the journal of critical care.

[56]  D. Postma.  When can an exacerbation of COPD be treated at home? , 1998, The Lancet.

[57]  R. S. Sen,et al.  Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin , 1998 .

[58]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[59]  J. Barberà,et al.  Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[60]  M. Wittmann.  [Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease]. , 1997, Pneumologie.

[61]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[62]  G. Snider,et al.  Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema. , 1996, Chest.

[63]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[64]  A. Buist,et al.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .

[65]  K. Chapman,et al.  Physician perceptions and management of COPD. , 1993, Chest.

[66]  G. Murata,et al.  Use of emergency medical services by patients with decompensated obstructive lung disease. , 1989, Annals of emergency medicine.

[67]  T. De,et al.  Parenteral nutrition before gastrointestinal surgery. , 1982 .

[68]  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.

[69]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.